PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 199 filers reported holding PDL BIOPHARMA INC in Q3 2016. The put-call ratio across all filers is 1.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $75,000 | -75.0% | 23,777 | -76.9% | 0.00% | – |
| Q2 2020 | $300,000 | +92.3% | 102,974 | +86.3% | 0.00% | – |
| Q1 2020 | $156,000 | -68.7% | 55,262 | -64.0% | 0.00% | – |
| Q4 2019 | $498,000 | +87.2% | 153,508 | +24.6% | 0.00% | – |
| Q3 2019 | $266,000 | -74.0% | 123,197 | -62.2% | 0.00% | -100.0% |
| Q2 2019 | $1,023,000 | +127.8% | 325,845 | +170.0% | 0.00% | – |
| Q1 2019 | $449,000 | -73.4% | 120,697 | -79.2% | 0.00% | -100.0% |
| Q4 2018 | $1,687,000 | +137.9% | 581,602 | +115.6% | 0.00% | +100.0% |
| Q3 2018 | $709,000 | +46.8% | 269,759 | +30.9% | 0.00% | – |
| Q2 2018 | $483,000 | -3.8% | 206,141 | +20.7% | 0.00% | – |
| Q1 2018 | $502,000 | -38.8% | 170,783 | -43.0% | 0.00% | -100.0% |
| Q4 2017 | $820,000 | +192.9% | 299,420 | +262.6% | 0.00% | – |
| Q3 2017 | $280,000 | +27900.0% | 82,583 | +13733.0% | 0.00% | – |
| Q2 2017 | $1,000 | -97.3% | 597 | -96.4% | 0.00% | – |
| Q1 2017 | $37,000 | -90.3% | 16,447 | -90.9% | 0.00% | – |
| Q4 2016 | $382,000 | +105.4% | 180,335 | +224.8% | 0.00% | – |
| Q3 2016 | $186,000 | -3.6% | 55,523 | -9.5% | 0.00% | – |
| Q2 2016 | $193,000 | -56.2% | 61,381 | -53.6% | 0.00% | – |
| Q1 2016 | $441,000 | +22.5% | 132,355 | +30.0% | 0.00% | – |
| Q4 2015 | $360,000 | +22.9% | 101,847 | +75.3% | 0.00% | – |
| Q3 2015 | $293,000 | -41.9% | 58,090 | -26.0% | 0.00% | – |
| Q2 2015 | $504,000 | -37.7% | 78,536 | -31.7% | 0.00% | -100.0% |
| Q1 2015 | $809,000 | -38.2% | 115,003 | -32.3% | 0.00% | 0.0% |
| Q4 2014 | $1,309,000 | +123.0% | 169,854 | +116.3% | 0.00% | 0.0% |
| Q3 2014 | $587,000 | +19.3% | 78,514 | +54.3% | 0.00% | – |
| Q2 2014 | $492,000 | -45.5% | 50,869 | -53.1% | 0.00% | -100.0% |
| Q1 2014 | $902,000 | +95.7% | 108,570 | +98.4% | 0.00% | – |
| Q4 2013 | $461,000 | +57.3% | 54,712 | +48.5% | 0.00% | – |
| Q3 2013 | $293,000 | +233.0% | 36,843 | +227.0% | 0.00% | – |
| Q2 2013 | $88,000 | – | 11,267 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nine Chapters Capital Management LLC | 119,700 | $254,000 | 0.43% |
| GSA CAPITAL PARTNERS LLP | 1,587,756 | $3,366,000 | 0.20% |
| AMERICAFIRST CAPITAL MANAGEMENT, LLC | 60,901 | $129,110,000 | 0.14% |
| Acrospire Investment Management LLC | 129,480 | $274,000 | 0.11% |
| SECOR Capital Advisors, LP | 410,323 | $870,000 | 0.11% |
| RBF Capital, LLC | 251,421 | $540,000 | 0.08% |
| Park West Asset Management LLC | 400,000 | $848,000 | 0.07% |
| MACKENZIE FINANCIAL CORP | 4,687,825 | $9,938,000 | 0.06% |
| CIGNA INVESTMENTS INC /NEW | 261,533 | $554,000,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 5,503,285 | $11,665,000 | 0.06% |